Replies to post #186981 on Biotech Values

[jaybe]

A little background on FDA's guidance for rescinding BTD's...

http://www.lexology.com/library/detail.aspx?g=5316130e-d527-42ea-89e4-b6063687e494

[jq1234]

What about BMY's BTD for Daclatasvir +  asunaprevir +  BMS-791325? I assume it will be rescinded as well.

[jq1234]

MRK just posted this non-inferiority ph3 study of 2-DAA FDC vs Sovaldi + PI + R in GT1/4/6. It seems very likely to me FDA had requested comparator non-inferiority study for future HCV drug approval based on their previous comment/guidance:

https://clinicaltrials.gov/ct2/show/NCT02358044